HedgePath Pharmaceuticals (HPPI) SEC Filings & 10K Form $0.05 +0.01 (+30.17%) As of 09/5/2025 Add Compare Share Share SEC Filings Stock AnalysisChartSEC FilingsBuy This Stock Recent HedgePath Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView05/14/20258:00 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 04/10/202512:30 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Vasisht Niraj (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:21 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Jerman Michael Allen (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:22 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)OSMAN RONALD E (Reporting)Ronald E Osman Irrevocable Trust III (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:23 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)SEARS SAMUEL P JR (Reporting)Form 4Statement of changes in beneficial ownership of securities 04/07/20254:25 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Yanez Michelle (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/19/20258:28 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)MCNULTY JAMES A (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 02/19/20258:27 PMHedgePath Pharmaceuticals (Issuer)Inhibitor Therapeutics, Inc. (Issuer)Yanez Michelle (Reporting)Form 5Annual statement of changes in beneficial ownership of securities 11/12/20245:27 AMHedgePath Pharmaceuticals (Filer)Inhibitor Therapeutics, Inc. (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies Genenta Science SEC Filings Sol-Gel Technologies SEC Filings Zomedica SEC Filings Immix Biopharma SEC Filings ABVC BioPharma SEC Filings Invizyne Technologies SEC Filings MiNK Therapeutics SEC Filings Werewolf Therapeutics SEC Filings Coeptis Therapeutics SEC Filings Karyopharm Therapeutics SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (OTCMKTS:HPPI) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HedgePath Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share HedgePath Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HPPI Stock Alerts